B-cell leukemia/lymphoma 2 (BCL-2) prevents commitment to programmed cell death at the
mitochondrion. It remains a challenge to identify those tumors that are best treated by …

Evasion of apoptosis is a hallmark of cancer. Bcl-2 and p53 represent two important nodes
in apoptosis signaling pathways. We find that concomitant p53 activation and Bcl-2 inhibition …

Despite high initial response rates, acute myeloid leukemia (AML) treated with the BCL-2–selective
inhibitor venetoclax (VEN) alone or in combinations commonly acquires resistance. …

… In this study, we showed that inhibition of Mcl-1 with a novel pan–… As a single agent, this
pan–Bcl-2 inhibitor effectively … These findings demonstrate that pan–Bcl-2 inhibition by an Mcl-1…

Background Although hypomethylating agents are currently used to treat patients with
cancer, whether they can also reactivate and up-regulate oncogenes is not well elucidated. …

Interest in harnessing natural killer (NK) cells for cancer immunotherapy is rapidly growing.
However, efficacy of NK cell-based immunotherapy remains limited in most trials. Strategies …

Purpose: Wnt/β-catenin signaling is required for leukemic stem cell function. FLT3 mutations
are frequently observed in acute myeloid leukemia (AML). Anomalous FLT3 signaling …

This paper investigates the adaptive event-triggered synchronization control problem for a
class of complex networks with quantization and cyber-attacks. For reducing the burden of …

A rapid and convenient method is presented for unmarked gene deletions in Pichia pastoris.
Cre/mutated lox system, Zeocin ® (Invitrogen) resistance marker and homologous arms …

Purpose: The persistence of leukemia stem cells (LSC)-containing cells after induction therapy
may contribute to minimal residual disease (MRD) and relapse in acute myeloid leukemia …